Why Fulgent Genetics Stock Was Crushing It on Friday

The next-generation diagnostics specialist had a beat-and-raise second quarter.Friday's stock market was generally a gloomy place, but apparently someone forgot to tell Fulgent Genetics (FLGT 7.80%). The company's shares were soaring in late-session action, with a very healthy rise of more than 8%. At that point, the bellwether S&P 500 index was mired in a funk with a nearly 2% decline. Fulgent's latest earnings release was a major reason for this dichotomy.A surprise on the bottom lineThat morning, before ...